Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Detection of invasive pulmonary aspergillosis in mice using lung perfusion single-photon emission computed tomography with [99mTc]MAA.

Yoshida M, Tashiro M, Nishi K, Mishima M, Kawano K, Takazono T, Saijo T, Yamamoto K, Imamura Y, Miyazaki T, Kudo T, Yanagihara K, Mukae H, Izumikawa K.

Med Mycol. 2020 Jan 14. pii: myz131. doi: 10.1093/mmy/myz131. [Epub ahead of print]

PMID:
31943043
2.

Severe Fever with Thrombocytopenia Syndrome Virus RNA in Semen, Japan.

Koga S, Takazono T, Ando T, Hayasaka D, Tashiro M, Saijo T, Kurihara S, Sekino M, Yamamoto K, Imamura Y, Miyazaki T, Yanagihara K, Morita K, Izumikawa K, Mukae H.

Emerg Infect Dis. 2019 Nov;25(11):2127-2128. doi: 10.3201/eid2511.190061.

3.

Munchausen syndrome mimicking refractory subcutaneous abscess with bacteremia, diagnosed by repetitive element sequence-based polymerase chain reaction: a case report.

Iwanaga N, Yamamoto K, Takazono T, Saijo T, Imamura Y, Miyazaki T, Izumikawa K, Yamamoto Y, Yanagihara K, Yasuoka A, Mukae H.

J Med Case Rep. 2019 Sep 12;13(1):287. doi: 10.1186/s13256-019-2212-7.

4.

Evaluation of Candida peritonitis with underlying peritoneal fibrosis and efficacy of micafungin in murine models of intra-abdominal candidiasis.

Ashizawa N, Miyazaki T, Abe S, Takazono T, Saijo T, Obata Y, Shimamura S, Yamamoto K, Imamura Y, Koji T, Nishino T, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

Sci Rep. 2019 Jun 27;9(1):9331. doi: 10.1038/s41598-019-45776-x.

5.

The Novel Arylamidine T-2307 Selectively Disrupts Yeast Mitochondrial Function by Inhibiting Respiratory Chain Complexes.

Yamashita K, Miyazaki T, Fukuda Y, Mitsuyama J, Saijo T, Shimamura S, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00374-19. doi: 10.1128/AAC.00374-19. Print 2019 Aug.

6.

The efficacy and safety of sitafloxacin and garenoxacin for the treatment of pneumonia in elderly patients: A randomized, multicenter, open-label trial.

Miyazaki T, Nakamura S, Hashiguchi K, Kobayashi T, Fukushima K, Fukuda Y, Kondo A, Inoue Y, Koga H, Sasaki E, Nagayoshi Y, Higashiyama Y, Yoshida M, Takazono T, Saijo T, Morinaga Y, Yamamoto K, Imamura Y, Mikushi S, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

J Infect Chemother. 2019 Nov;25(11):886-893. doi: 10.1016/j.jiac.2019.04.019. Epub 2019 May 18.

7.

Efficacy and safety of cefditoren pivoxil for exacerbations of chronic obstructive pulmonary disease: A prospective multicenter interventional study.

Miyazaki T, Fukushima K, Hashiguchi K, Inoue Y, Mihara T, Sawai T, Suyama N, Kobayashi T, Kondo A, Fukuda Y, Harada Y, Sasaki E, Kaku N, Ide S, Takazono T, Saijo T, Kosai K, Morinaga Y, Nakamura S, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

J Infect Chemother. 2019 Sep;25(9):702-707. doi: 10.1016/j.jiac.2019.03.018. Epub 2019 Apr 11.

8.

Selection of oral antifungals for initial maintenance therapy in chronic pulmonary aspergillosis: A longitudinal analysis.

Tashiro M, Takazono T, Saijo T, Yamamoto K, Imamura Y, Miyazaki T, Kakeya H, Ando T, Ogawa K, Kishi K, Tokimatsu I, Hayashi Y, Fujiuchi S, Yanagihara K, Miyazaki Y, Ichihara K, Mukae H, Kohno S, Izumikawa K.

Clin Infect Dis. 2019 Apr 9. pii: ciz287. doi: 10.1093/cid/ciz287. [Epub ahead of print]

PMID:
30959519
9.

Evaluation of Aspergillus-Specific Lateral-Flow Device Test Using Serum and Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.

Takazono T, Ito Y, Tashiro M, Nishimura K, Saijo T, Yamamoto K, Imamura Y, Miyazaki T, Yanagihara K, Mukae H, Izumikawa K.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e00095-19. doi: 10.1128/JCM.00095-19. Print 2019 May.

10.

Autophagy-Inducing Factor Atg1 Is Required for Virulence in the Pathogenic Fungus Candida glabrata.

Shimamura S, Miyazaki T, Tashiro M, Takazono T, Saijo T, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

Front Microbiol. 2019 Jan 25;10:27. doi: 10.3389/fmicb.2019.00027. eCollection 2019.

11.

Clinical features and cause analysis of false positive results of Aspergillus galactomannan assay in pulmonary cryptococcosis patients.

Takazono T, Saijo T, Ashizawa N, Oshima K, Nishimura K, Tashiro M, Yamamoto K, Imamura Y, Miyazaki T, Yanagihara K, Mukae H, Izumikawa K, Sheppard DC.

Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):735-741. doi: 10.1007/s10096-019-03469-3. Epub 2019 Jan 25.

PMID:
30684164
12.

Vacuolar proton-translocating ATPase is required for antifungal resistance and virulence of Candida glabrata.

Minematsu A, Miyazaki T, Shimamura S, Nishikawa H, Nakayama H, Takazono T, Saijo T, Yamamoto K, Imamura Y, Yanagihara K, Kohno S, Mukae H, Izumikawa K.

PLoS One. 2019 Jan 23;14(1):e0210883. doi: 10.1371/journal.pone.0210883. eCollection 2019.

13.

A case of bilateral emphysematous pyelonephritis caused by Candida albicans.

Ideguchi S, Yamamoto K, Ikeda A, Hashimoto K, Takazono T, Saijo T, Imamura Y, Miyazaki T, Mukae H.

J Infect Chemother. 2019 Apr;25(4):302-306. doi: 10.1016/j.jiac.2018.10.011. Epub 2018 Nov 15. Review.

PMID:
30448360
14.

Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas aeruginosa.

Kosai K, Kaku N, Uno N, Saijo T, Morinaga Y, Imamura Y, Hasegawa H, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K.

Open Microbiol J. 2018 Sep 28;12:321-322. doi: 10.2174/1874285801812010321. eCollection 2018. No abstract available.

15.

Primary Oral Mucormycosis Due to Rhizopus microsporus after Allogeneic Stem Cell Transplantation.

Sakamoto H, Itonaga H, Sawayama Y, Taguchi J, Saijo T, Kuwatsuka S, Hashisako M, Kinoshita N, Oishi M, Doi H, Kosai K, Nishimoto K, Tanaka K, Yanagihara K, Mukae H, Izumikawa K, Miyazaki Y.

Intern Med. 2018;57(17):2567-2571. doi: 10.2169/internalmedicine.0474-17. Epub 2018 Sep 1.

16.

Clinical and Microbiological Characteristics of Candida guilliermondii and Candida fermentati.

Hirayama T, Miyazaki T, Yamagishi Y, Mikamo H, Ueda T, Nakajima K, Takesue Y, Higashi Y, Yamamoto Y, Kimura M, Araoka H, Taniguchi S, Fukuda Y, Matsuo Y, Furutani A, Yamashita K, Takazono T, Saijo T, Shimamura S, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e02528-17. doi: 10.1128/AAC.02528-17. Print 2018 Jun.

17.

Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia.

Tashiro M, Fushimi K, Kawano K, Takazono T, Saijo T, Yamamoto K, Kurihara S, Imamura Y, Miyazaki T, Yanagihara K, Mukae H, Izumikawa K.

BMC Pulm Med. 2017 Dec 29;17(1):219. doi: 10.1186/s12890-017-0566-4.

18.

Comparison of Efficacy of Antimicrobial Agents Among Hospitalized Patients With Mycoplasma pneumoniae Pneumonia in Japan During Large Epidemics of Macrolide-Resistant M. pneumoniae Infections: A Nationwide Observational Study.

Tashiro M, Fushimi K, Kawano K, Takazono T, Saijo T, Yamamoto K, Kurihara S, Imamura Y, Miyazaki T, Yanagihara K, Mukae H, Izumikawa K.

Clin Infect Dis. 2017 Nov 13;65(11):1837-1842. doi: 10.1093/cid/cix695.

PMID:
29020161
19.

Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas Aeruginosa.

Kosai K, Kaku N, Uno N, Saijo T, Morinaga Y, Imamura Y, Hasegawa H, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K.

Open Microbiol J. 2017 May 31;11:92-97. doi: 10.2174/1874285801711010092. eCollection 2017.

20.

Examination of cryptococcal glucuronoxylomannan antigen in bronchoalveolar lavage fluid for diagnosing pulmonary cryptococcosis in HIV-negative patients.

Oshima K, Takazono T, Saijo T, Tashiro M, Kurihara S, Yamamoto K, Imamura Y, Miyazaki T, Tsukamoto M, Yanagihara K, Mukae H, Kohno S, Izumikawa K.

Med Mycol. 2018 Jan 1;56(1):88-94. doi: 10.1093/mmy/myx010.

PMID:
28419364

Supplemental Content

Loading ...
Support Center